Established risk factors for oral cancer including tobacco (smoking, chewing), alcohol, etc., have shown to cause an increase in the salivary acetaldehyde (ACH) levels. 1 The ACH has shown carcinogenic potential in animal models and the International Agency for the Research on Cancer considers ACH to be a possible carcinogen in humans. 2 The ACH can cause mutagenic deoxyribonucleic acid adduct formations at levels > 40 µM. 3, 4 Studies have shown the ability of several microorganisms to increase ACH to carcinogenic levels in saliva. The most extensively studied organism is Candida albicans. Although the mere presence of C. albicans does not indicate a high-risk state, the ACH salivary levels of patients with chronic candidal infections could be a risk factor for oral cancer. 5 In vitro studies have shown that even non-C. albicans species can form carcinogenic ACH levels in saliva. Candida glabrata and Candida tropicalis were shown to be the most potential carcinogenic non-C. albicans species for their ability
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to form carcinogenic levels of ACH from glucose and ethanol respectively. 1 Patients treated for oral cancer are prone to develop oral candidal mucositis due to change in the tissue microenvironment. These patients are often treated with azoles which eliminate C. albicans, but are largely ineffective against azole-resistant non-C. albicans species. Such patients have shown to develop new primary carcinoma in areas of chronic oral candidal mucositis. 1, 6 To conclude, it is of utmost importance that treatmentresistant chronic oral candidal mucositis especially in susceptible patients (postchemo and radiotherapy) is closely followed up and periodically analyzed for salivary ACH levels. Further large-scale multicenter prospective studies are necessary to substantiate the results from the in vitro studies.
